Lanvis (treatment of leukaemias)

c.1974 -c.1981
Part of:
Wellcome Foundation Ltd
  • Archives and manuscripts

About this work


Lanvis (treatment of leukaemias). Cytostatic agent. Main indication is acute myeloblastic leukaemia, but it has also been used in acute lymphoblasic and chronic granulocytic leukaemia. Used in cancer chemotherapy, in tablet form.

The folder includes a photocopy extract from Wellcome Medical Division, page 1102 re. Lanvis Tablets; colour transparancy of Lanvis product;"Dear Sir" and "Dear Doctor" letters, a bibliography of published papers; booklets on Lanvis for clinicians and therapy for leukaemia.


c.1974 -c.1981

Physical description

1 Item

Copyright note

Copyright assigned to the Wellcome Trust

Where to find it

  • LocationStatusAccess
    Closed stores

Permanent link